Help The Kashmir Monitor sustain so that we continue to be editorially independent. Remember, your contributions, however small they may be, matter to us.

Over 1L Hydroxychloroquine tablets procured for treating COVID 19 patients in Kashmir

Capture 10


 Srinagar:  Doctors have started giving Hydroxychloroquine to COVID-19 patients in Kashmir after Indian Council of Medical Research (ICMR) approved the anti-malaria drug for treating the deadly infection.

Indian Council of Medical Research (ICMR) recently approved Hydroxychloroquine along with Azithromycin for COVID-19 treatment. 

 

Soon after, Jammu and Kashmir administration procured more than 100,000 Hydroxychloroquine tablets. 

“We have procured 110000 tablets of Hydroxychloroquine which have been now distributed to the hospitals in Jammu and Kashmir,” General Manager Jammu and Kashmir Medical Supplies Corporation Limited Mohammad Iqbal said. 

More than 30,000 tablets have been handed over to Directorate of Health Services Kashmir, 15,000 to Government Medical College (GMC) Srinagar, 5,000 each to SKIMS Bemina, GMC Baramulla, and GMC Anantnag. 

Medical Superintendent Dr. Naveed Shah told The Kashmir Monitor that they are giving hydroxychloroquine to those COVID-19 patients who have no history of cardiac complications. 

“Patients with mild or moderate infection are being given this drug. Azithromycin is also being given to the patients. Further, Ivermectin and second-line anti-HIV drugs are also given depending on the severity of the patient, “he said. 

Dr. Naveed said that majority of the patients in Chest Diseases hospital have shown signs of recovery after being administered these drugs. 

Of the 30 COVID-19 positive patients at SKIMS, around 22 are being given Hydroxychloroquine. 

Dr. Aijaz Nabi Koul, who is currently treating COVID-19 patients, said all the patients in the Institute have shown signs of recovery. 

“All my patients are doing good. I had three sick patients who have made a very good improvement,” he said. 

Dr. Koul said doctors conduct ECG of the COVID-19 positive patients before giving them Hydroxychloroquine.  “We have divided patients into two groups. Only selected patients are given Hydroxychloroquine and some other drugs. We are currently analyzing how effective this drug can be in the recovery of COVID-19 patients, “he said. 

Dr. Koul said the earlier ICMR approved drugs including Lopinavir and Ritonavi have also proved effective in treating COVID 19 patients. 

“The first COVID-19 case was a 67- year old lady. She was very sick and had almost collapsed. She was given these two drugs for 72 hours and she showed immediate signs of recovery. So far three patients have been discharged from SKIMS who were given these drugs, “he said.